Pharmacogenomics

Pharmacogenomics  is the study of the role of genetics in drug response. Computational advances in Pharmacogenomics has proven to be a blessing in research. A large amount of research in the biomedical sciences regarding Pharmacogenomics as of late stems from combinatorial chemistry,[53] genomic mining, omic technologies and high throughput screening. In order for the field to grow rich knowledge enterprises and business must work more closely together and adopt simulation strategies. Major Universities dealing Pharmacogenomics are:  Harvard University, US, , University of Cambridge, UK, National University of Singapore, Singapore, University of Oxford, UK, Karolinska Institute, Sweden, Monash University, Australia, Imperial College London, UK, University of Tokyo, Japan, University of Melbourne, Australia, University of Michigan, US.

    Related Conference of Pharmacogenomics

    August 22-23, 2019

    5th International Congress on Epigenetics & Chromatin

    Vienna, Austria
    August 30-31, 2019

    International Conference on Genetic Disorders

    Bangkok, Thailand
    September 13-14, 2019

    12th World Congress on Cell & Tissue Science

    Singapore
    October 21-22, 2019

    23rd European Biotechnology Congress

    Zurich, Switzerland
    November 26-27, 2019

    International Conference On Genomics and Molecular Biology

    Lisbon | Portugal
    November 26-27, 2019

    International Conference on Cell and Gene Therapy

    | Lisbon, Portugal
    February 24-25, 2020

    24th Global Congress on Biotechnology

    London, UK
    March 16-17, 2020 |

    12th World Congress and Expo on Cell & Stem Cell Research

    Chicago, Illinois, USA
    May 21-22, 2020

    24th European Biotechnology Congress

    London,UK

    Pharmacogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in